FTSJ1

Across TCGA pan-cancer cohorts, FTSJ1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated FTSJ1 data layer compared with 28 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher FTSJ1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated FTSJ1 expression acts as an unfavorable survival marker.

LSCC, PDAC, and CCRCC are the cancer types where FTSJ1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	DFS	Quartile	All	0.576	0.909	.010	17	view →
PDAC	DFS	Tertile	All	0.583	0.825	.014	8	view →
CCRCC	DFS	Tertile	II,III,IV	0.500	1.000	.034	4	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

FTSJ1–LSCC (DFS)

Open the LSCC breakdown →